Chelsey Goss, OD | |
3615 Se Kentucky St, Bartlesville, OK 74006 | |
(918) 252-2020 | |
Not Available |
Full Name | Chelsey Goss |
---|---|
Gender | Female |
Speciality | Optometry |
Experience | 3 Years |
Location | 3615 Se Kentucky St, Bartlesville, Oklahoma |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1154094142 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | 3125 (Oklahoma) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Triad Eye Institute Pllc | 6507083557 | 23 |
News Archive
"Hospital executives who have worked with Dr. Berwick describe him as a visionary, inspiring leader. But a battle has erupted over his nomination, suggesting that Dr. Berwick faces a long uphill struggle to win Senate confirmation. Republicans are using the nomination to revive their arguments against the new health care law, which they see as a potent issue in this fall's elections, and Dr. Berwick has given them plenty of ammunition. In two decades as a professor of health policy and as a prolific writer, he has spoken of the need to ration health care and cap spending and has confessed to a love affair with the British health care system."
A new study of French women has found that high beta-carotene intake-through a combination of diet or supplementation-is associated with a higher risk of tobacco-related cancers in smokers, but the risk of these cancers decreases with increasing beta-carotene intake in nonsmokers.
GlaxoSmithKline and Genmab A/S Following the 1st July announcement by GSK and Genmab of an amendment to the collaborative agreement for ofatumumab in which GSK assumed development responsibility for autoimmune indications, GSK and Genmab announced today plans to refocus the development program of ofatumumab in autoimmune indications.
The Drugs for Neglected Diseases initiative (DNDi) and Medicines for Malaria Venture (MMV) announce today the identification of three chemical series targeting the treatment of deadly neglected tropical diseases (NTDs), through DNDi's screening of MMV's open access Malaria Box.
The Board of Directors of Aetna declared a quarterly cash dividend of $0.225 per share on the company's common stock.
› Verified 1 days ago
Provider Name | Triad Eye Institute Pllc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1093743213 PECOS PAC ID: 6507083557 Enrollment ID: O20140918000152 |
News Archive
"Hospital executives who have worked with Dr. Berwick describe him as a visionary, inspiring leader. But a battle has erupted over his nomination, suggesting that Dr. Berwick faces a long uphill struggle to win Senate confirmation. Republicans are using the nomination to revive their arguments against the new health care law, which they see as a potent issue in this fall's elections, and Dr. Berwick has given them plenty of ammunition. In two decades as a professor of health policy and as a prolific writer, he has spoken of the need to ration health care and cap spending and has confessed to a love affair with the British health care system."
A new study of French women has found that high beta-carotene intake-through a combination of diet or supplementation-is associated with a higher risk of tobacco-related cancers in smokers, but the risk of these cancers decreases with increasing beta-carotene intake in nonsmokers.
GlaxoSmithKline and Genmab A/S Following the 1st July announcement by GSK and Genmab of an amendment to the collaborative agreement for ofatumumab in which GSK assumed development responsibility for autoimmune indications, GSK and Genmab announced today plans to refocus the development program of ofatumumab in autoimmune indications.
The Drugs for Neglected Diseases initiative (DNDi) and Medicines for Malaria Venture (MMV) announce today the identification of three chemical series targeting the treatment of deadly neglected tropical diseases (NTDs), through DNDi's screening of MMV's open access Malaria Box.
The Board of Directors of Aetna declared a quarterly cash dividend of $0.225 per share on the company's common stock.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Chelsey Goss, OD 6140 S Memorial Dr, Tulsa, OK 74133-1933 Ph: (918) 252-2020 | Chelsey Goss, OD 3615 Se Kentucky St, Bartlesville, OK 74006 Ph: (918) 252-2020 |
News Archive
"Hospital executives who have worked with Dr. Berwick describe him as a visionary, inspiring leader. But a battle has erupted over his nomination, suggesting that Dr. Berwick faces a long uphill struggle to win Senate confirmation. Republicans are using the nomination to revive their arguments against the new health care law, which they see as a potent issue in this fall's elections, and Dr. Berwick has given them plenty of ammunition. In two decades as a professor of health policy and as a prolific writer, he has spoken of the need to ration health care and cap spending and has confessed to a love affair with the British health care system."
A new study of French women has found that high beta-carotene intake-through a combination of diet or supplementation-is associated with a higher risk of tobacco-related cancers in smokers, but the risk of these cancers decreases with increasing beta-carotene intake in nonsmokers.
GlaxoSmithKline and Genmab A/S Following the 1st July announcement by GSK and Genmab of an amendment to the collaborative agreement for ofatumumab in which GSK assumed development responsibility for autoimmune indications, GSK and Genmab announced today plans to refocus the development program of ofatumumab in autoimmune indications.
The Drugs for Neglected Diseases initiative (DNDi) and Medicines for Malaria Venture (MMV) announce today the identification of three chemical series targeting the treatment of deadly neglected tropical diseases (NTDs), through DNDi's screening of MMV's open access Malaria Box.
The Board of Directors of Aetna declared a quarterly cash dividend of $0.225 per share on the company's common stock.
› Verified 1 days ago
Jamie A. Bennett, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 401 E Silas St, Bartlesville, OK 74003 Phone: 918-336-4068 | |
Eyecare Of Bartlesville Optometrist Medicare: Medicare Enrolled Practice Location: 311 Se Delaware Ave, Bartlesville, OK 74003 Phone: 918-336-0607 | |
Jamie Archer Bennett, Od,pc Optometrist Medicare: Medicare Enrolled Practice Location: 401 East Silas St., Bartlesville, OK 74003 Phone: 918-336-4068 Fax: 918-336-4084 | |
Phillip E Foust, Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1725 Se Washington Blvd, Suite A, Bartlesville, OK 74006 Phone: 918-333-3636 Fax: 918-335-1725 | |
Dr. Jerry Carter, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2419 Nowata Pl, Suite 103, Bartlesville, OK 74006 Phone: 918-333-9292 Fax: 918-333-9295 | |
Dr. Leslie Faulkner, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 311 Se Delaware Ave, Bartlesville, OK 74003 Phone: 918-336-0607 |